Originalkatalog | Verfügbarkeit prüfen

LBA27 First-line systemic treatment in patients with initially unresectable colorectal cancer liver metastases (CRLM): Overall survival of the phase III CAIRO5 study of the Dutch C...

Punt, C.J.A., Bond, M.J.G., Bolhuis, K., Loosveld, O.J.L., de Groot, J.W., Droogendijk, H., Helgason, H.H., Hendriks, M.P., Klaase, J.M., Kazemier, G., Liem, M.S.L., Rijken, A.M., Verhoef, C., de Wilt, J.H.W., de Jong, K.P., van Amerongen, M.J., De Valk, B., Kerver, E.D., Komurcu, A., Swijnenburg, R-J.
Veröffentlicht in: Annals of Oncology ; volume 34, page S1268 ; ISSN 0923-7534;
2023

Originalkatalog | Verfügbarkeit prüfen

LBA21 FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tu...

Bond, M.J.G., Bolhuis, K., Loosveld, O.J.L., Droogendijk, H.J., de Groot, J.W.B., Hendriks, M.P., De Valk, B., Liem, M.S.L., Rijken, A.M., Verhoef, K., de Wilt, J.H.W., de Jong, K.P., Kazemier, G., van Amerongen, M.J., Engelbrecht, M.R.W., Klaase, J.M., Komurcu, A., Lopez-Yurda, M.I., Swijnenburg, R-J., Punt, C.J.A.
Veröffentlicht in: Annals of Oncology ; volume 33, page S1389 ; ISSN 0923-7534;
2022